Taken together, these discoveries imply that orexin-A has the potential to alleviate cerebral ischemia–reperfusion injury by inhibiting apoptosis mediated by ERS, thereby elucidating the mechanism underlying its neuroprotective properties (Table 2). The gene discussed is HCRT; the disease is brain ischemia.